Ehrig Torsten, Cockerell Clay, Piacquadio Daniel, Dromgoole Syd
Cockerell and Associates Dermatopathology Laboratory, Dallas, Texas, USA.
Dermatol Surg. 2006 Oct;32(10):1261-5. doi: 10.1111/j.1524-4725.2006.32287.x.
The ability to clinically diagnose actinic keratoses (AKs) lesions has been taken for granted for some time. The importance of the malignant potential of these lesions is well known. However, a recent Phase IV, multicenter study assessing the long-term benefit of aminolevulinic acid-based photodynamic therapy provided a unique opportunity to prospectively examine the clinical histopathologic correlation of AKs.
The objective was to characterize the histopathology of clinically diagnosed AK lesions in the study population.
Punch biopsies of 220 clinically diagnosed untreated AKs were performed at baseline plus 51 lesions unresponsive to treatment (total, 271).
Clinical diagnosis and histopathologic findings agreed in 91% (246/271) of the lesions biopsied. The balance of the biopsied lesions were: (1) benign changes 4% (11/271) and (2) occult cutaneous malignancy in 5% (14/271) of the cases, 12 squamous cell carcinomas and 2 basal cell carcinomas.
In this study, about 1 in 25 clinically diagnosed AK lesions identified by board-certified dermatologist investigator(s) were occult early-stage squamous cell carcinomas on histologic assessment, a fact surmised by the medical community that until now had not been well quantified. These findings should be considered when clinicians decide how to treat and manage AK patients.
一段时间以来,临床诊断光化性角化病(AK)病变的能力一直被视为理所当然。这些病变的恶性潜能的重要性是众所周知的。然而,最近一项评估基于氨基乙酰丙酸的光动力疗法长期益处的IV期多中心研究提供了一个独特的机会,可以前瞻性地研究AK的临床组织病理学相关性。
目的是描述研究人群中临床诊断的AK病变的组织病理学特征。
在基线时对220例临床诊断为未经治疗的AK进行了打孔活检,另外对51例治疗无反应的病变进行了活检(共271例)。
活检的病变中,91%(246/271)的临床诊断与组织病理学结果一致。其余活检病变为:(1)良性改变4%(11/271),(2)隐匿性皮肤恶性肿瘤5%(14/271),其中12例为鳞状细胞癌,2例为基底细胞癌。
在本研究中,经皮肤科专科医生临床诊断的AK病变中,约每25例中有1例在组织学评估中为隐匿性早期鳞状细胞癌,这一事实此前虽被医学界推测,但一直未得到很好的量化。临床医生在决定如何治疗和管理AK患者时应考虑这些发现。